AU3048601A - Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients - Google Patents

Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients

Info

Publication number
AU3048601A
AU3048601A AU3048601A AU3048601A AU3048601A AU 3048601 A AU3048601 A AU 3048601A AU 3048601 A AU3048601 A AU 3048601A AU 3048601 A AU3048601 A AU 3048601A AU 3048601 A AU3048601 A AU 3048601A
Authority
AU
Australia
Prior art keywords
bio
mutra
infective
enhancer
nutrients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU3048601A
Inventor
Suman Preet Singh Khanuja
Sushil Kumar
Ajit Kumar Shasany
Jai Shankar Arya
Mahendra Pandurang Darokar
Monika Singh
Prachi Sinha
Soumya Awasthi
Subhash Chandra Gupta
Vivek Kumar Gupta
Madan Mohan Gupta
Ram Kishore Verma
Sweta Agarwal
Sunil Balkrishna Mansinghka
Suresh Haribhau Dawle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of AU3048601A publication Critical patent/AU3048601A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The invention relates to a novel pharmaceutical composition comprising an effective amount of bio-active fraction form cow urine distillate as a bioavailability facilitor and pharmaceutically acceptable additives selected from anticancer compounds, antibiotics, drugs, therapeutic and nutraceutic agents, ions and similar molecules which are targeted to the living systems.
AU3048601A 2000-10-20 2000-10-20 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients Pending AU3048601A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2000/000106 WO2002032436A1 (en) 2000-10-20 2000-10-20 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients

Publications (1)

Publication Number Publication Date
AU3048601A true AU3048601A (en) 2002-04-29

Family

ID=11076279

Family Applications (3)

Application Number Title Priority Date Filing Date
AU3048601A Pending AU3048601A (en) 2000-10-20 2000-10-20 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
AU2001230486A Ceased AU2001230486B2 (en) 2000-10-20 2000-10-20 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
AU2005237162A Ceased AU2005237162B2 (en) 2000-10-20 2005-11-25 Pharmaceutical composition containing cow urine distillate and an antibiotic

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2001230486A Ceased AU2001230486B2 (en) 2000-10-20 2000-10-20 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
AU2005237162A Ceased AU2005237162B2 (en) 2000-10-20 2005-11-25 Pharmaceutical composition containing cow urine distillate and an antibiotic

Country Status (11)

Country Link
EP (1) EP1330253B1 (en)
KR (1) KR100848394B1 (en)
CN (2) CN100536856C (en)
AT (1) ATE273014T1 (en)
AU (3) AU3048601A (en)
BR (1) BR0017342A (en)
CA (1) CA2425025C (en)
DE (1) DE60012996T2 (en)
DK (1) DK1330253T3 (en)
MX (1) MXPA03002653A (en)
WO (1) WO2002032436A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087176A1 (en) * 2003-03-31 2004-10-14 Council Of Scientific And Industrial Research A composition (rucd) for protecting and/or repairing dna from oxidative damages and a method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248295A (en) * 1962-12-26 1966-04-26 Canadian Patents Dev Anti-allergic urine extract and method of making same
KR100523463B1 (en) * 2003-05-30 2005-10-25 영남대학교 산학협력단 Composition comprising the extract of Astilbe rubra or Astilbic acid and Peltoboykinolic acid derivatives having anti-inflammatory or anti-allergic activity

Also Published As

Publication number Publication date
KR100848394B1 (en) 2008-07-24
DE60012996T2 (en) 2005-01-27
AU2005237162A1 (en) 2005-12-22
DE60012996D1 (en) 2004-09-16
ATE273014T1 (en) 2004-08-15
MXPA03002653A (en) 2004-01-29
WO2002032436A1 (en) 2002-04-25
CN100536856C (en) 2009-09-09
KR20040015010A (en) 2004-02-18
BR0017342A (en) 2004-02-03
CA2425025A1 (en) 2002-04-25
CN1788735A (en) 2006-06-21
EP1330253B1 (en) 2004-08-11
CN1454092A (en) 2003-11-05
DK1330253T3 (en) 2004-10-04
CA2425025C (en) 2010-11-23
AU2005237162B2 (en) 2007-02-08
EP1330253A1 (en) 2003-07-30
AU2001230486B2 (en) 2005-11-10
CN1234372C (en) 2006-01-04

Similar Documents

Publication Publication Date Title
ATE235895T1 (en) DRUG DELIVERY SYSTEM CONTAINING A HARD-PACKED, SOLID DRUG BASE
NZ527157A (en) Compositions for delivering bisphosphonates
BR0309875A (en) methods and compositions for treating peripheral nervous system disorders and novel compounds useful therefor
IL172082A0 (en) Foamable pharmaceutical compositions and methods for treating a disorder
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
HRP20060275B1 (en) 6-0-supstituted ketolides having antibacterial activity
IL159843A0 (en) Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
EP1140840A4 (en) -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
BR9405798A (en) Methods for in vivo release of biological material and useful compositions thereof
CA2359510A1 (en) .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ATE345775T1 (en) COMPOSITIONS FOR ADMINISTRATION OF DRUG COMBINATIONS
HK1056728A1 (en) Ortho-substituted anthranilic acid amides and their use as medicaments
MXPA03007857A (en) Compounds and compositions for delivering active agents.
ZA200704285B (en) Reverse micelles based on phytosterols and acyglycerols and therapeutic uses thereof
ATE317846T1 (en) PHOSPHORAMIDATE PRODRUGS
TW200509985A (en) Drug delivery system for sub-Tenon administration of fine particles
AU3048601A (en) Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
MY138502A (en) Novel alkansulfonamides as endothelin antagonists
ATE299704T1 (en) HOT-FORMED SOLID MEDICINAL COMPOSITION FOR THE CONTROLLED DELIVERY OF PERINDOPRIL
MXPA05003844A (en) Glucose-based compounds with affinity to p-selectin.